STOCK TITAN

LeMaitre Will Announce Third Quarter 2023 Earnings Results November 1, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
LeMaitre Vascular to release Q3 2023 financial results
Positive
  • Investors can access the live conference call and webcast to discuss the financial results, business highlights, and company outlook.
Negative
  • None.

BURLINGTON, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2023 financial results on Wednesday, November 1, 2023, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.


FAQ

When will LeMaitre Vascular release its Q3 2023 financial results?

LeMaitre Vascular will release its Q3 2023 financial results on Wednesday, November 1, 2023.

What time is the conference call scheduled for?

The conference call is scheduled for 5:00 PM EDT on November 1, 2023.

How can I access the live call and webcast?

Investors can register online to receive dial-in information and a PIN for the live call. The webcast can also be accessed live or via replay at www.lemaitre.com/investor.

LeMaitre Vascular, Inc.

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Stock Data

1.50B
20.03M
10.21%
91.35%
3.47%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
BURLINGTON

About LMAT

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.